Orthofix Medical (OFIX) Capital Expenditures (2010 - 2026)

Orthofix Medical has disclosed Capital Expenditures across 17 years of filings, most recently posting $10.7 million for Q1 2026.

• Quarterly Capital Expenditures rose 58.27% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.6 million (up 25.19% YoY) and the FY2025 annual result came in at $34.6 million, down 0.72% from the prior year.
• Capital Expenditures fell to $10.7 million in Q1 2026, from $10.9 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $21.9 million in Q3 2023 and troughed at $5.1 million in Q3 2022.
• A 5-year average of $9.7 million and a median of $9.7 million in 2024 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures surged 326.6% — and 2024, when it plunged 73.43%.
• Tracing OFIX's Capital Expenditures over 5 years: stood at $7.0 million in 2022, then soared by 133.61% to $16.4 million in 2023, then plunged by 47.84% to $8.5 million in 2024, then climbed by 27.5% to $10.9 million in 2025, then retreated by 1.99% to $10.7 million in 2026.
• Business Quant data shows OFIX's Capital Expenditures at $10.7 million in Q1 2026, $10.9 million in Q4 2025, and $9.9 million in Q3 2025.